Escandallo, Lyka L.
HRN: 16-46-97 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2023
CEFUROXIME 750MG (VIAL)
06/30/2023
07/06/2023
IV
320mg
Q8
Urti
Waiting Final Action
06/30/2023
CEFTRIAXONE 1G (VIAL)
06/30/2023
07/06/2023
IV
970
Q24
Urti
Waiting Final Action